NatureWise Biotech & Medicals Corporation (TPEX:4732)
Taiwan · Delayed Price · Currency is TWD 16.60
+0.30 (1.84%)
Aug 4, 2026, 1:00 PM CST
TPEX:4732 Financials Overview
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 176.77 | 176.77 | 224.32 | 160.14 | 228.59 | 249.8 |
Revenue Growth | -1.96% | -21.20% | 40.08% | -29.94% | -8.49% | -18.61% |
Gross Profit Gross Profit Growth | 85.7 | 85.7 | 120.2 | 87.38 | 129.93 | 146.19 |
Operating Income Operating Income Growth | -106.87 | -106.87 | -12.02 | 3.43 | 26.35 | 26.98 |
Net Income Net Income Growth | -92.28 | -92.28 | 0.9 | 10.12 | 30.02 | 30.81 |
Earnings Per Share EPS Growth | -1.89 | -1.89 | 0.02 | 0.20 | 0.61 | 0.62 |
EPS Growth | - | - | -90.90% | -67.17% | -1.75% | -53.03% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Taiwan Taiwan Growth | 172.1 | 172.1 | 222.21 | 160.14 | 228.02 | 249.77 |
Mainland China Mainland China Growth | 4.5 | 4.5 | 2.11 | - | - | - |
Other Other Growth | 0.17 | 0.17 | - | - | - | - |
Total Total Growth | 176.77 | 176.77 | 224.32 | 160.14 | 228.59 | 249.8 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 470.39 | 470.39 | 614.73 | 475.26 | 493.98 | 497.87 |
Total Debt Total Debt Growth | 11.49 | 11.49 | 3.4 | 7.78 | 2.7 | 6.64 |
Net Cash (Debt) Net Cash Growth | 458.9 | 458.9 | 611.33 | 467.48 | 491.28 | 491.23 |
Net Cash Growth | -19.99% | -24.93% | 30.77% | -4.84% | 0.01% | 4.65% |
Net Cash Per Share Net Cash Per Share Growth | 9.42 | 9.42 | 12.27 | 9.37 | 9.93 | 9.96 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | -111.74 | -111.74 | -2.8 | 62.2 | 13.85 | 33.72 |
Capital Expenditures CapEx Growth | -0.84 | -0.84 | -0.12 | -0.31 | - | - |
Free Cash Flow Free Cash Flow Growth | -112.58 | -112.58 | -2.91 | 61.9 | 13.85 | 33.72 |
Free Cash Flow Growth | - | - | - | 346.81% | -58.92% | -38.25% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 48.48% | 48.48% | 53.58% | 54.56% | 56.84% | 58.52% |
Operating Margin | -60.46% | -60.46% | -5.36% | 2.14% | 11.53% | 10.80% |
Pretax Margin | -57.44% | -57.44% | -1.63% | 6.20% | 13.13% | 12.27% |
Profit Margin | -52.20% | -52.20% | 0.40% | 6.32% | 13.13% | 12.33% |
FCF Margin | -63.69% | -63.69% | -1.30% | 38.65% | 6.06% | 13.50% |
| Fiscal Year | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|
| Period Ending | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Dividend Per Share Dividend Per Share Growth | 0.200 | 0.500 | 0.300 |
Dividend Per Share Growth | -60.00% | 66.67% | 218.13% |
Dividend Yield | 0.84% | 1.66% | 0.69% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 4, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | - | - | 1371.24 | 132.72 | 57.87 | 82.24 |
P/FCF Ratio | - | - | - | 21.70 | 125.42 | 75.14 |
PS Ratio | 4.31 | 5.66 | 5.48 | 8.39 | 7.60 | 10.14 |